Group 1 - The company will hold a performance briefing on June 17, 2025, from 15:00 to 16:00 to discuss the 2024 annual report and the first quarter report of 2025 [3][4] - Investors can submit questions before the meeting through a designated website or WeChat mini-program, and the company will address common concerns during the briefing [2][5] - The meeting will be conducted in an online interactive format, allowing for broader participation from investors [4][5] Group 2 - Key participants in the meeting will include the Chairman, Secretary of the Board, Financial Officer, and an Independent Director, with potential adjustments due to special circumstances [4] - After the meeting, investors can access the main content and outcomes through the designated online platforms [6]
证券代码：600479 证券简称：千金药业 公告编号：2025-034